Reducing the pressure in pulmonary arterial hypertension: sotatercept, haemodynamics and the right ventricle

Eur Respir J. 2023 Sep 21;62(3):2301513. doi: 10.1183/13993003.01513-2023. Print 2023 Sep.

Authors

Laura C Price^{1

2}, Colm McCabe^{3

2}, Jason Weatherald⁴

Affiliations

¹ National Pulmonary Hypertension Service, Royal Brompton Hospital, London, UK laura.price@rbht.nhs.uk.
² National Heart and Lung Institute, Imperial College London, London, UK.
³ National Pulmonary Hypertension Service, Royal Brompton Hospital, London, UK.
⁴ Department of Medicine, Division of Pulmonary Medicine, University of Alberta, Edmonton, AB, Canada.

PMID: 37696566
DOI: 10.1183/13993003.01513-2023

No abstract available

Publication types

Editorial
Comment

MeSH terms

Familial Primary Pulmonary Hypertension
Heart
Heart Ventricles*
Hemodynamics
Humans
Pulmonary Arterial Hypertension* / drug therapy

Substances

ACE-011